Tissue microarray analysis of expression of vascular endothelial growth factor and platelet-derived endothelial cell growth factor in a-fetoprotein-negative hepatocellular carcinoma and its relationship with prognosis after radical resection

陆清,徐泱,周俭,樊嘉,纪元,汤钊猷
DOI: https://doi.org/10.3321/j.issn:1001-9030.2008.07.003
2008-01-01
Abstract:Objective To study the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PD-ECGF) and its relationship with the prognosis after radical resection for α-fetoprotein (AFP)-negative hepatocellular carcinoma (HCC). Methods The expression of VEGF and PD-ECGF in 200 patients with AFP-negative HCC proven by surgery and pathology during Jan. 1997 to Dec. 2000 was analyzed retrospectively by high-throughput tissue microarray technology and immnnohistochemistry. Kaplan-Meier method, log-rank test and chi-square test were used to analyze the relationship between the expression of the two angiogenetie factors with the prognosis of AFP-negative HCC. Results Compared with VEGF-positive group and PD-ECGF-positive group,the patients' survivalrate and tumor-free survival rate rather than recurrence rate had no significant difference in the negative-expression group, respectively. The recurrence rate was also higher in the both positive groups than in the both negative groups. Moreover, the patients in both positive groups had a significantly low survival and tumor-free survival rate. Conclusion Positive expression of both VEGF and PD-ECGF indicated high risk of tumor recurrence and a poor prognosis after radical resection for AFP-negative HCC.
What problem does this paper attempt to address?